Literature DB >> 17463093

From the liver to the brain across the blood-brain barrier.

Vivian I Teichberg1.   

Abstract

Mesh：

Year:  2007        PMID： 17463093      PMCID： PMC1863474          DOI： 10.1073/pnas.0702450104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 2.  Blood-brain barrier delivery.

Authors:  William M Pardridge
Journal:  Drug Discov Today       Date:  2006-11-13       Impact factor: 7.851

3.  Molecular Trojan horses for blood-brain barrier drug delivery.

Authors:  William M Pardridge
Journal:  Discov Med       Date:  2006-08       Impact factor: 2.970

Review 4.  The blood-brain barrier and brain drug delivery.

Authors:  J M Koziara; P R Lockman; D D Allen; R J Mumper
Journal:  J Nanosci Nanotechnol       Date:  2006 Sep-Oct

5.  Targeted delivery of proteins across the blood-brain barrier.

Authors:  Brian J Spencer; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

Review 6.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Authors:  R A Kroll; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

Review 7.  Convection-enhanced delivery in clinical trials.

Authors:  Walter A Hall; Edward Rustamzadeh; Anthony L Asher
Journal:  Neurosurg Focus       Date:  2003-02-15       Impact factor: 4.047

8.  Drug "diffusion" within the brain.

Authors:  J Fenstermacher; T Kaye
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

9.  Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.

Authors:  Y Shen; S I Muramatsu; K Ikeguchi; K I Fujimoto; D S Fan; M Ogawa; H Mizukami; M Urabe; A Kume; I Nagatsu; F Urano; T Suzuki; H Ichinose; T Nagatsu; J Monahan; I Nakano; K Ozawa
Journal:  Hum Gene Ther       Date:  2000-07-20       Impact factor: 5.695

10.  Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression.

Authors:  Q Yan; C Matheson; J Sun; M J Radeke; S C Feinstein; J A Miller
Journal:  Exp Neurol       Date:  1994-05       Impact factor: 5.330
View more
  11 in total

1.  The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach.

Authors:  Dmitry Frank; Ruslan Kuts; Philip Tsenter; Benjamin F Gruenbaum; Yulia Grinshpun; Vladislav Zvenigorodsky; Ilan Shelef; Dmitry Natanel; Evgeny Brotfain; Alexander Zlotnik; Matthew Boyko
Journal:  Neuropharmacology       Date:  2019-05-31       Impact factor: 5.250

2.  The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.

Authors:  Matthew Boyko; Israel Melamed; Benjamin Fredrick Gruenbaum; Shaun Evan Gruenbaum; Sharon Ohayon; Akiva Leibowitz; Evgeny Brotfain; Yoram Shapira; Alexander Zlotnik
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 3.  Site-specific opening of the blood-brain barrier.

Authors:  Steen J Madsen; Henry Hirschberg
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

4.  Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.

Authors:  Matthew Boyko; David Stepensky; Benjamin F Gruenbaum; Shaun E Gruenbaum; Israel Melamed; Sharon Ohayon; Michael Glazer; Yoram Shapira; Alexander Zlotnik
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

5.  MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.

Authors:  Adela Bonoiu; Supriya D Mahajan; Ling Ye; Rajiv Kumar; Hong Ding; Ken-Tye Yong; Indrajit Roy; Ravikumar Aalinkeel; Bindukumar Nair; Jessica L Reynolds; Donald E Sykes; Marco A Imperiale; Earl J Bergey; Stanley A Schwartz; Paras N Prasad
Journal:  Brain Res       Date:  2009-05-27       Impact factor: 3.252

6.  OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability.

Authors:  Hanmei Bao; Xu Jin; Ling Li; Feng Lv; Tianjun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

7.  Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction.

Authors:  Junyi Shen; Zhiming Zhao; Wei Shang; Chunli Liu; Beibei Zhang; Lingjie Zhao; Hui Cai
Journal:  Int J Nanomedicine       Date:  2017-09-05

8.  Safety evaluation of frequent application of microbubble-enhanced focused ultrasound blood-brain-barrier opening.

Authors:  Hong-Chieh Tsai; Chih-Hung Tsai; Wen-Shiang Chen; Claude Inserra; Kuo-Chen Wei; Hao-Li Liu
Journal:  Sci Rep       Date:  2018-12-07       Impact factor: 4.379

Review 9.  Blood glutamate scavenging: insight into neuroprotection.

Authors:  Akiva Leibowitz; Matthew Boyko; Yoram Shapira; Alexander Zlotnik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208

Review 10.  Glutamate as a neurotransmitter in the healthy brain.

Authors:  Y Zhou; N C Danbolt
Journal:  J Neural Transm (Vienna)       Date:  2014-03-01       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.